<table id="id_42ee6cb7-34b7-4d35-b3df-cc7029dd7248" width="430.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_063217b9-597e-4c37-8bb6-0bae23a3c6ee">Table 4 PRURITUS SYMPTOM SCORE Changes in the First Week of a Clinical Trial in Patients with Chronic Idiopathic Urticaria</caption>
<col align="center" width="30.0%"></col>
<col align="center" width="20.0%"></col>
<col align="center" width="20.0%"></col>
<col align="center" width="30.0%"></col>
<thead>
<tr id="id_8848363e-9eec-4528-8d0d-0bef47a980bc" stylecode="Botrule">
<td align="left" stylecode="Rrule" valign="top">Treatment Group<br/>(n)</td>
<td align="left" stylecode="Rrule" valign="top">Mean Baseline<br/>(sem)</td>
<td align="left" stylecode="Rrule" valign="top">Change from Baseline<footnote id="id-5a59fa52-f71c-4a6c-a1e1-cb86898c19e6">Mean reduction in pruritus averaged over the first week of treatment.</footnote>
<br/>(sem)</td>
<td align="left" valign="top">Placebo Comparison<br/>(<content stylecode="italics">P</content>-value)</td>
</tr>
</thead>
<tfoot id="id_b5659919-7d50-4c01-9128-05d4ff01a7be">
<tr>
<td align="left" colspan="4" valign="top">Pruritus scored 0 to 3 where 0=no symptom to 3=maximal symptom.</td>
</tr>
</tfoot>
<tbody>
<tr id="id_9d501654-943f-48d9-adda-2af72ba8e168" stylecode="Toprule">
<td align="left" valign="top">CLARINEX 5.0 mg (115)</td>
<td align="left" stylecode="Toprule" valign="top">2.19 (0.04)</td>
<td align="left" stylecode="Toprule" valign="top">-1.05 (0.07)</td>
<td align="left" valign="top">
<content stylecode="italics">P</content>&lt;0.01</td>
</tr>
<tr id="id_cb1eb21b-48a0-4dbc-a357-dea1c0ef833e">
<td align="left" valign="top">Placebo (110)</td>
<td align="left" valign="top">2.21 (0.04)</td>
<td align="left" valign="top">-0.52 (0.07)</td>
<td align="left" valign="top"></td>
</tr>
</tbody>
</table>